{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,20]],"date-time":"2026-02-20T07:23:56Z","timestamp":1771572236319,"version":"3.50.1"},"reference-count":62,"publisher":"Japanese Society of Veterinary Science","issue":"5","funder":[{"DOI":"10.13039\/501100001691","name":"Japan Society for the Promotion of Science","doi-asserted-by":"publisher","award":["JP23K27063"],"award-info":[{"award-number":["JP23K27063"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001691","name":"Japan Society for the Promotion of Science","doi-asserted-by":"publisher","award":["JP23K27068"],"award-info":[{"award-number":["JP23K27068"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J. Vet. Med. Sci.","The Journal of Veterinary Medical Science"],"published-print":{"date-parts":[[2025]]},"DOI":"10.1292\/jvms.25-0011","type":"journal-article","created":{"date-parts":[[2025,4,2]],"date-time":"2025-04-02T22:06:37Z","timestamp":1743631597000},"page":"517-531","source":"Crossref","is-referenced-by-count":4,"title":["Genomic characteristics and distinctive genetic polymorphisms of Marek\u2019s disease virus strains circulating in Japan"],"prefix":"10.1292","volume":"87","author":[{"given":"Shunsuke","family":"YAMAGAMI","sequence":"first","affiliation":[{"name":"Laboratory of Infectious Diseases, Department of Disease Control, Faculty of Veterinary Medicine, Hokkaido University, Hokkaido, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jumpei","family":"SATO","sequence":"additional","affiliation":[{"name":"Laboratory of Infectious Diseases, Department of Disease Control, Faculty of Veterinary Medicine, Hokkaido University, Hokkaido, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yoshinosuke","family":"MOTAI","sequence":"additional","affiliation":[{"name":"Laboratory of Infectious Diseases, Department of Disease Control, Faculty of Veterinary Medicine, Hokkaido University, Hokkaido, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Naoya","family":"MAEKAWA","sequence":"additional","affiliation":[{"name":"Department of Advanced Pharmaceutics, Faculty of Veterinary Medicine, Hokkaido University, Hokkaido, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tomohiro","family":"OKAGAWA","sequence":"additional","affiliation":[{"name":"Department of Advanced Pharmaceutics, Faculty of Veterinary Medicine, Hokkaido University, Hokkaido, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Satoru","family":"KONNAI","sequence":"additional","affiliation":[{"name":"Laboratory of Infectious Diseases, Department of Disease Control, Faculty of Veterinary Medicine, Hokkaido University, Hokkaido, Japan"},{"name":"Department of Advanced Pharmaceutics, Faculty of Veterinary Medicine, Hokkaido University, Hokkaido, Japan"},{"name":"Veterinary Research Unit, International Institute for Zoonosis Control, Hokkaido University, Hokkaido, Japan"},{"name":"Institute for Vaccine Research and Development (HU-IVReD), Hokkaido University, Hokkaido, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kazuhiko","family":"OHASHI","sequence":"additional","affiliation":[{"name":"Laboratory of Infectious Diseases, Department of Disease Control, Faculty of Veterinary Medicine, Hokkaido University, Hokkaido, Japan"},{"name":"Department of Advanced Pharmaceutics, Faculty of Veterinary Medicine, Hokkaido University, Hokkaido, Japan"},{"name":"Veterinary Research Unit, International Institute for Zoonosis Control, Hokkaido University, Hokkaido, Japan"},{"name":"International Affairs Office, Faculty of Veterinary Medicine, Hokkaido University, Hokkaido, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shiro","family":"MURATA","sequence":"additional","affiliation":[{"name":"Laboratory of Infectious Diseases, Department of Disease Control, Faculty of Veterinary Medicine, Hokkaido University, Hokkaido, Japan"},{"name":"Department of Advanced Pharmaceutics, Faculty of Veterinary Medicine, Hokkaido University, Hokkaido, Japan"},{"name":"Veterinary Research Unit, International Institute for Zoonosis Control, Hokkaido University, Hokkaido, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"122","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1. Bertzbach LD, Conradie AM, You Y, Kaufer BB.  2020. Latest insights into Marek\u2019s disease virus pathogenesis and tumorigenesis. <i>Cancers (Basel)<\/i> 12: 647.","DOI":"10.3390\/cancers12030647"},{"key":"2","doi-asserted-by":"crossref","unstructured":"2. Brown AC, Baigent SJ, Smith LP, Chattoo JP, Petherbridge LJ, Hawes P, Allday MJ, Nair V.  2006. Interaction of MEQ protein and C-terminal-binding protein is critical for induction of lymphomas by Marek\u2019s disease virus. <i>Proc Natl Acad Sci USA<\/i> 103: 1687\u20131692.","DOI":"10.1073\/pnas.0507595103"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3. Calnek BW.  2001. Pathogenesis of Marek\u2019s disease virus infection. <i>Curr Top Microbiol Immunol<\/i> 255: 25\u201355.","DOI":"10.1007\/978-3-642-56863-3_2"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4. Chac\u00f3n RD, S\u00e1nchez-Llatas CJ, L Pajuelo S, Diaz Forero AJ, Jimenez-Vasquez V, M\u00e9dico JA, Soto-Ugaldi LF, Astolfi-Ferreira CS, Piantino Ferreira AJ.  2024. Molecular characterization of the <i>meq<\/i> oncogene of Marek\u2019s disease virus in vaccinated Brazilian poultry farms reveals selective pressure on prevalent strains. <i>Vet Q<\/i> 44: 1\u201313.","DOI":"10.1080\/01652176.2024.2318198"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5. Cheng Y, Cong F, Zhang YP, Li ZJ, Xu NN, Hou GY, Liu CJ.  2012. Genome sequence determination and analysis of a Chinese virulent strain, LMS, of Gallid herpesvirus type 2. <i>Virus Genes<\/i> 45: 56\u201362.","DOI":"10.1007\/s11262-012-0739-4"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6. Conradie AM, Bertzbach LD, Trimpert J, Patria JN, Murata S, Parcells MS, Kaufer BB.  2020. Distinct polymorphisms in a single herpesvirus gene are capable of enhancing virulence and mediating vaccinal resistance. <i>PLoS Pathog<\/i> 16: e1009104.","DOI":"10.1371\/journal.ppat.1009104"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7. Darriba D, Posada D, Kozlov AM, Stamatakis A, Morel B, Flouri T.  2020. ModelTest-NG: a new and scalable tool for the selection of DNA and protein evolutionary models. <i>Mol Biol Evol<\/i> 37: 291\u2013294.","DOI":"10.1093\/molbev\/msz189"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8. Deng X, Li X, Shen Y, Qiu Y, Shi Z, Shao D, Jin Y, Chen H, Ding C, Li L, Chen P, Ma Z.  2010. The Meq oncoprotein of Marek\u2019s disease virus interacts with p53 and inhibits its transcriptional and apoptotic activities. <i>Virol J<\/i> 7: 348.","DOI":"10.1186\/1743-422X-7-348"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9. Dunn JR, Black Pyrkosz A, Steep A, Cheng HH.  2019. Identification of Marek\u2019s disease virus genes associated with virulence of US strains. <i>J Gen Virol<\/i> 100: 1132\u20131139.","DOI":"10.1099\/jgv.0.001288"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10. Gonz\u00e1lez CM, Wang L, Damania B.  2009. Kaposi\u2019s sarcoma-associated herpesvirus encodes a viral deubiquitinase. <i>J Virol<\/i> 83: 10224\u201310233.","DOI":"10.1128\/JVI.00589-09"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11. Hasegawa M, Kishino H, Yano T.  1985. Dating of the human-ape splitting by a molecular clock of mitochondrial DNA. <i>J Mol Evol<\/i> 22: 160\u2013174.","DOI":"10.1007\/BF02101694"},{"key":"12","doi-asserted-by":"crossref","unstructured":"12. He L, Li J, Peng P, Nie J, Luo J, Cao Y, Xue C.  2020. Genomic analysis of a Chinese MDV strain derived from vaccine strain CVI988 through recombination. <i>Infect Genet Evol<\/i> 78: 104045.","DOI":"10.1016\/j.meegid.2019.104045"},{"key":"13","doi-asserted-by":"crossref","unstructured":"13. Izumiya Y, Jang HK, Sugawara M, Ikeda Y, Miura R, Nishimura Y, Nakamura K, Miyazawa T, Kai C, Mikami T.  1999. Identification and transcriptional analysis of the homologues of the herpes simplex virus type 1 UL30 to UL40 genes in the genome of nononcogenic Marek\u2019s disease virus serotype 2. <i>J Gen Virol<\/i> 80: 2417\u20132422.","DOI":"10.1099\/0022-1317-80-9-2417"},{"key":"14","doi-asserted-by":"crossref","unstructured":"14. Jarosinski K, Kattenhorn L, Kaufer B, Ploegh H, Osterrieder N.  2007. A herpesvirus ubiquitin-specific protease is critical for efficient T cell lymphoma formation. <i>Proc Natl Acad Sci USA<\/i> 104: 20025\u201320030.","DOI":"10.1073\/pnas.0706295104"},{"key":"15","doi-asserted-by":"crossref","unstructured":"15. Jarosinski KW, Tischer BK, Trapp S, Osterrieder N.  2006. Marek\u2019s disease virus: lytic replication, oncogenesis and control. <i>Expert Rev Vaccines<\/i> 5: 761\u2013772.","DOI":"10.1586\/14760584.5.6.761"},{"key":"16","doi-asserted-by":"crossref","unstructured":"16. Katoh K, Standley DM.  2013. MAFFT multiple sequence alignment software version 7: improvements in performance and usability. <i>Mol Biol Evol<\/i> 30: 772\u2013780.","DOI":"10.1093\/molbev\/mst010"},{"key":"17","doi-asserted-by":"crossref","unstructured":"17. Kim T, Hearn CJ, Mays J, Velez-Irizarry D, Reddy SM, Spatz SJ, Cheng HH, Dunn JR.  2023. Phenotypic Characterization of Recombinant marek\u2019s disease virus in live birds validates polymorphisms associated with virulence. <i>Viruses<\/i> 15: 2263.","DOI":"10.3390\/v15112263"},{"key":"18","doi-asserted-by":"crossref","unstructured":"18. Kozlov AM, Darriba D, Flouri T, Morel B, Stamatakis A.  2019. RAxML-NG: a fast, scalable and user-friendly tool for maximum likelihood phylogenetic inference. <i>Bioinformatics<\/i> 35: 4453\u20134455.","DOI":"10.1093\/bioinformatics\/btz305"},{"key":"19","doi-asserted-by":"crossref","unstructured":"19. Kung HJ, Xia L, Brunovskis P, Li D, Liu JL, Lee LF.  2001. Meq: an MDV-specific bZIP transactivator with transforming properties. <i>Curr Top Microbiol Immunol<\/i> 255: 245\u2013260.","DOI":"10.1007\/978-3-642-56863-3_10"},{"key":"20","doi-asserted-by":"crossref","unstructured":"20. Lee JI, Sollars PJ, Baver SB, Pickard GE, Leelawong M, Smith GA.  2009. A herpesvirus encoded deubiquitinase is a novel neuroinvasive determinant. <i>PLoS Pathog<\/i> 5: e1000387.","DOI":"10.1371\/journal.ppat.1000387"},{"key":"21","doi-asserted-by":"crossref","unstructured":"21. Lee LF, Wu P, Sui D, Ren D, Kamil J, Kung HJ, Witter RL.  2000. The complete unique long sequence and the overall genomic organization of the GA strain of Marek\u2019s disease virus. <i>Proc Natl Acad Sci USA<\/i> 97: 6091\u20136096.","DOI":"10.1073\/pnas.97.11.6091"},{"key":"22","doi-asserted-by":"crossref","unstructured":"22. Letunic I, Bork P.  2024. Interactive tree of life (iTOL) v6: recent updates to the phylogenetic tree display and annotation tool. <i>Nucleic Acids Res<\/i> 52 W1: W78\u2013W82.","DOI":"10.1093\/nar\/gkae268"},{"key":"23","doi-asserted-by":"crossref","unstructured":"23. Li H, Zhu J, He M, Luo Q, Liu F, Chen R.  2018. Marek\u2019s disease virus activates the PI3K\/Akt pathway through interaction of its protein Meq with the P85 subunit of PI3K to promote viral replication. <i>Front Microbiol<\/i> 9: 2547.","DOI":"10.3389\/fmicb.2018.02547"},{"key":"24","doi-asserted-by":"crossref","unstructured":"24. Li K, Liu Y, Xu Z, Zhang Y, Luo D, Gao Y, Qian Y, Bao C, Liu C, Zhang Y, Qi X, Cui H, Wang Y, Gao L, Wang X.  2019. Avian oncogenic herpesvirus antagonizes the cGAS-STING DNA-sensing pathway to mediate immune evasion. <i>PLoS Pathog<\/i> 15: e1007999.","DOI":"10.1371\/journal.ppat.1007999"},{"key":"25","doi-asserted-by":"crossref","unstructured":"25. Li K, Yu Z, Lan X, Wang Y, Qi X, Cui H, Gao L, Wang X, Zhang Y, Gao Y, Liu C.  2022. Complete genome analysis reveals evolutionary history and temporal dynamics of Marek\u2019s disease virus. <i>Front Microbiol<\/i> 13: 1046832.","DOI":"10.3389\/fmicb.2022.1046832"},{"key":"26","doi-asserted-by":"crossref","unstructured":"26. Liu JL, Kung HJ.  2000. Marek\u2019s disease herpesvirus transforming protein MEQ: a c-Jun analogue with an alternative life style. <i>Virus Genes<\/i> 21: 51\u201364.","DOI":"10.1007\/978-1-4615-1707-8_5"},{"key":"27","doi-asserted-by":"crossref","unstructured":"27. Lupiani B, Lee LF, Reddy SM.  2001. Protein-coding content of the sequence of Marek\u2019s disease virus serotype 1. <i>Curr Top Microbiol Immunol<\/i> 255: 159\u2013190.","DOI":"10.1007\/978-3-642-56863-3_7"},{"key":"28","doi-asserted-by":"crossref","unstructured":"28. Lv H, Zhang Y, Sun G, Bao K, Gao Y, Qi X, Cui H, Wang Y, Li K, Gao L, Pan Q, Wang X, Liu C.  2017. Genetic evolution of Gallid herpesvirus 2 isolated in China. <i>Infect Genet Evol<\/i> 51: 263\u2013274.","DOI":"10.1016\/j.meegid.2016.04.027"},{"key":"29","doi-asserted-by":"crossref","unstructured":"29. Machida Y, Murata S, Matsuyama-Kato A, Isezaki M, Taneno A, Sakai E, Konnai S, Ohashi K.  2017. Isolation and purification of Gallid herpesvirus 2 strains currently distributed in Japan. <i>J Vet Med Sci<\/i> 79: 115\u2013122.","DOI":"10.1292\/jvms.16-0329"},{"key":"30","doi-asserted-by":"crossref","unstructured":"30. Murata S, Hashiguchi T, Hayashi Y, Yamamoto Y, Matsuyama-Kato A, Takasaki S, Isezaki M, Onuma M, Konnai S, Ohashi K.  2013. Characterization of Meq proteins from field isolates of Marek\u2019s disease virus in Japan. <i>Infect Genet Evol<\/i> 16: 137\u2013143.","DOI":"10.1016\/j.meegid.2012.12.032"},{"key":"31","doi-asserted-by":"crossref","unstructured":"31. Murata S, Machida Y, Isezaki M, Maekawa N, Okagawa T, Konnai S, Ohashi K.  2020. Genetic characterization of a Marek\u2019s disease virus strain isolated in Japan. <i>Virol J<\/i> 17: 186.","DOI":"10.1186\/s12985-020-01456-1"},{"key":"32","doi-asserted-by":"crossref","unstructured":"32. Niikura M, Dodgson J, Cheng H.  2006. Direct evidence of host genome acquisition by the alphaherpesvirus Marek\u2019s disease virus. <i>Arch Virol<\/i> 151: 537\u2013549.","DOI":"10.1007\/s00705-005-0633-7"},{"key":"33","doi-asserted-by":"crossref","unstructured":"33. Padhi A, Parcells MS.  2016. Positive selection drives rapid evolution of the meq oncogene of marek\u2019s disease virus. <i>PLoS One<\/i> 11: e0162180.","DOI":"10.1371\/journal.pone.0162180"},{"key":"34","doi-asserted-by":"crossref","unstructured":"34. Posada D.  2003. Using MODELTEST and PAUP* to select a model of nucleotide substitution. <i>Curr Protoc Bioinformatics Chapter<\/i><b>6<\/b>. <i>Unit<\/i> 6: 5.","DOI":"10.1002\/0471250953.bi0605s00"},{"key":"35","doi-asserted-by":"crossref","unstructured":"35. Raja A, Dhinakar Raj G, Bhuvaneswari P, Balachandran C, Kumanan K.  2009. Detection of virulent Marek\u2019s disease virus in poultry in India. <i>Acta Virol<\/i> 53: 255\u2013260.","DOI":"10.4149\/av_2009_04_255"},{"key":"36","doi-asserted-by":"crossref","unstructured":"36. Renz KG, Cooke J, Clarke N, Cheetham BF, Hussain Z, Fakhrul Islam AF, Tannock GA, Walkden-Brown SW.  2012. Pathotyping of Australian isolates of Marek\u2019s disease virus and association of pathogenicity with meq gene polymorphism. <i>Avian Pathol<\/i> 41: 161\u2013176.","DOI":"10.1080\/03079457.2012.656077"},{"key":"37","doi-asserted-by":"crossref","unstructured":"37. Schat KA.  2016. History of the first-generation marek\u2019s disease vaccines: the science and little-known facts. <i>Avian Dis<\/i> 60: 715\u2013724.","DOI":"10.1637\/11429-050216-Hist"},{"key":"38","doi-asserted-by":"crossref","unstructured":"38. Schat KA, Calnek BW, Fabricant J.  1982. Characterisation of two highly oncogenic strains of Marek\u2019s disease virus. <i>Avian Pathol<\/i> 11: 593\u2013605.","DOI":"10.1080\/03079458208436134"},{"key":"39","doi-asserted-by":"crossref","unstructured":"39. Shamblin CE, Greene N, Arumugaswami V, Dienglewicz RL, Parcells MS.  2004. Comparative analysis of Marek\u2019s disease virus (MDV) glycoprotein-, lytic antigen pp38- and transformation antigen Meq-encoding genes: association of meq mutations with MDVs of high virulence. <i>Vet Microbiol<\/i> 102: 147\u2013167.","DOI":"10.1016\/j.vetmic.2004.06.007"},{"key":"40","doi-asserted-by":"crossref","unstructured":"40. Silva RF, Lee LF, Kutish GF.  2001. The genomic structure of Marek\u2019s disease virus. <i>Curr Top Microbiol Immunol<\/i> 255: 143\u2013158.","DOI":"10.1007\/978-3-642-56863-3_6"},{"key":"41","doi-asserted-by":"crossref","unstructured":"41. Spatz SJ, Rue CA.  2008. Sequence determination of a mildly virulent strain (CU-2) of Gallid herpesvirus type 2 using 454 pyrosequencing. <i>Virus Genes<\/i> 36: 479\u2013489.","DOI":"10.1007\/s11262-008-0213-5"},{"key":"42","doi-asserted-by":"crossref","unstructured":"42. Spatz SJ, Silva RF.  2007. Sequence determination of variable regions within the genomes of gallid herpesvirus-2 pathotypes. <i>Arch Virol<\/i> 152: 1665\u20131678.","DOI":"10.1007\/s00705-007-0992-3"},{"key":"43","doi-asserted-by":"crossref","unstructured":"43. Spatz SJ, Petherbridge L, Zhao Y, Nair V.  2007. Comparative full-length sequence analysis of oncogenic and vaccine (Rispens) strains of Marek\u2019s disease virus. <i>J Gen Virol<\/i> 88: 1080\u20131096.","DOI":"10.1099\/vir.0.82600-0"},{"key":"44","doi-asserted-by":"crossref","unstructured":"44. Spatz SJ, Rue C, Schumacher D, Osterrieder N.  2008. Clustering of mutations within the inverted repeat regions of a serially passaged attenuated gallid herpesvirus type 2 strain. <i>Virus Genes<\/i> 37: 69\u201380.","DOI":"10.1007\/s11262-008-0242-0"},{"key":"45","doi-asserted-by":"crossref","unstructured":"45. Spatz SJ, Smith LP, Baigent SJ, Petherbridge L, Nair V.  2011. Genotypic characterization of two bacterial artificial chromosome clones derived from a single DNA source of the very virulent gallid herpesvirus-2 strain C12\/130. <i>J Gen Virol<\/i> 92: 1500\u20131507.","DOI":"10.1099\/vir.0.027706-0"},{"key":"46","doi-asserted-by":"crossref","unstructured":"46. Spatz SJ, Volkening JD, Gimeno IM, Heidari M, Witter RL.  2012. Dynamic equilibrium of Marek\u2019s disease genomes during in vitro serial passage. <i>Virus Genes<\/i> 45: 526\u2013536.","DOI":"10.1007\/s11262-012-0792-z"},{"key":"47","doi-asserted-by":"crossref","unstructured":"47. Su S, Cui N, Cui Z, Zhao P, Li Y, Ding J, Dong X.  2012. Complete genome sequence of a recombinant Marek\u2019s disease virus field strain with one reticuloendotheliosis virus long terminal repeat insert. <i>J Virol<\/i> 86: 13818\u201313819.","DOI":"10.1128\/JVI.02583-12"},{"key":"48","doi-asserted-by":"crossref","unstructured":"48. Sugaya K, Bradley G, Nonoyama M, Tanaka A.  1990. Latent transcripts of Marek\u2019s disease virus are clustered in the short and long repeat regions. <i>J Virol<\/i> 64: 5773\u20135782.","DOI":"10.1128\/jvi.64.12.5773-5782.1990"},{"key":"49","doi-asserted-by":"crossref","unstructured":"49. Sun GR, Zhang YP, Lv HC, Zhou LY, Cui HY, Gao YL, Qi XL, Wang YQ, Li K, Gao L, Pan Q, Wang XM, Liu CJ.  2017. A Chinese variant Marek\u2019s disease virus strain with divergence between virulence and vaccine resistance. <i>Viruses<\/i> 9: 71.","DOI":"10.3390\/v9040071"},{"key":"50","unstructured":"50. Tamura K, Nei M.  1993. Estimation of the number of nucleotide substitutions in the control region of mitochondrial DNA in humans and chimpanzees. <i>Mol Biol Evol<\/i> 10: 512\u2013526."},{"key":"51","unstructured":"51. Tavar\u00e9 S.  1986. Some probabilistic and statistical problems in the analysis of DNA sequences. <i>Lect Math Life Sci<\/i> 17: 57\u201386."},{"key":"52","doi-asserted-by":"crossref","unstructured":"52. Trimpert J, Groenke N, Jenckel M, He S, Kunec D, Szpara ML, Spatz SJ, Osterrieder N, McMahon DP.  2017. A phylogenomic analysis of Marek\u2019s disease virus reveals independent paths to virulence in Eurasia and North America. <i>Evol Appl<\/i> 10: 1091\u20131101.","DOI":"10.1111\/eva.12515"},{"key":"53","doi-asserted-by":"crossref","unstructured":"53. Tulman ER, Afonso CL, Lu Z, Zsak L, Rock DL, Kutish GF.  2000. The genome of a very virulent Marek\u2019s disease virus. <i>J Virol<\/i> 74: 7980\u20137988.","DOI":"10.1128\/JVI.74.17.7980-7988.2000"},{"key":"54","doi-asserted-by":"crossref","unstructured":"54. Whitehurst CB, Vaziri C, Shackelford J, Pagano JS.  2012. Epstein-Barr virus BPLF1 deubiquitinates PCNA and attenuates polymerase \u03b7 recruitment to DNA damage sites. <i>J Virol<\/i> 86: 8097\u20138106.","DOI":"10.1128\/JVI.00588-12"},{"key":"55","doi-asserted-by":"crossref","unstructured":"55. Witter RL.  1997. Increased virulence of Marek\u2019s disease virus field isolates. <i>Avian Dis<\/i> 41: 149\u2013163.","DOI":"10.2307\/1592455"},{"key":"56","doi-asserted-by":"crossref","unstructured":"56. Witter RL.  1998. Control strategies for Marek\u2019s disease: a perspective for the future. <i>Poult Sci<\/i> 77: 1197\u20131203.","DOI":"10.1093\/ps\/77.8.1197"},{"key":"57","doi-asserted-by":"crossref","unstructured":"57. Witter RL, Calnek BW, Buscaglia C, Gimeno IM, Schat KA.  2005. Classification of Marek\u2019s disease viruses according to pathotype: philosophy and methodology. <i>Avian Pathol<\/i> 34: 75\u201390.","DOI":"10.1080\/03079450500059255"},{"key":"58","doi-asserted-by":"crossref","unstructured":"58. Xie Q, Anderson AS, Morgan RW.  1996. Marek\u2019s disease virus (MDV) ICP4, pp38, and meq genes are involved in the maintenance of transformation of MDCC-MSB1 MDV-transformed lymphoblastoid cells. <i>J Virol<\/i> 70: 1125\u20131131.","DOI":"10.1128\/jvi.70.2.1125-1131.1996"},{"key":"59","doi-asserted-by":"crossref","unstructured":"59. Zhang F, Liu CJ, Zhang YP, Li ZJ, Liu AL, Yan FH, Cong F, Cheng Y.  2012. Comparative full-length sequence analysis of Marek\u2019s disease virus vaccine strain 814. <i>Arch Virol<\/i> 157: 177\u2013183.","DOI":"10.1007\/s00705-011-1131-8"},{"key":"60","doi-asserted-by":"crossref","unstructured":"60. Zhang Y, Lan X, Wang Y, Lin Y, Yu Z, Guo R, Li K, Cui H, Qi X, Wang Y, Gao L, Pan Q, Liu A, Gao Y, Wang X, Liu C.  2022. Emerging natural recombinant Marek\u2019s disease virus between vaccine and virulence strains and their pathogenicity. <i>Transbound Emerg Dis<\/i> 69: e1702\u2013e1709.","DOI":"10.1111\/tbed.14506"},{"key":"61","doi-asserted-by":"crossref","unstructured":"61. Zhang YP, Bao KY, Sun GR, Lv HC, Cui HY, Gao YL, Wang XM, Liu CJ.  2017. Characterization of a Gallid herpesvirus 2 strain with novel reticuloendotheliosis virus long terminal repeat inserts. <i>Virus Genes<\/i> 53: 386\u2013391.","DOI":"10.1007\/s11262-017-1427-1"},{"key":"62","doi-asserted-by":"crossref","unstructured":"62. Zhou X, Wu S, Zhou H, Wang M, Wang M, L\u00fc Y, Cheng Z, Xu J, Ai Y.  2019. Marek\u2019s disease virus regulates the ubiquitylome of chicken CD4<sup>+<\/sup> T cells to promote tumorigenesis. <i>Int J Mol Sci<\/i> 20: 2089.","DOI":"10.3390\/ijms20092089"}],"container-title":["Journal of Veterinary Medical Science"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/jvms\/87\/5\/87_25-0011\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,17]],"date-time":"2025-05-17T03:34:05Z","timestamp":1747452845000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/jvms\/87\/5\/87_25-0011\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025]]},"references-count":62,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2025]]}},"URL":"https:\/\/doi.org\/10.1292\/jvms.25-0011","relation":{},"ISSN":["0916-7250","1347-7439"],"issn-type":[{"value":"0916-7250","type":"print"},{"value":"1347-7439","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025]]},"article-number":"25-0011"}}